BARCLAYS PLC - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 32 filers reported holding REPROS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$01240.0%0.00%
Q3 2017$0124
-44.6%
0.00%
Q2 2017$0
-100.0%
224
-97.9%
0.00%
Q1 2017$13,000
+18.2%
10,455
+28.5%
0.00%
Q4 2016$11,000
-84.7%
8,139
-76.5%
0.00%
Q3 2016$72,000
+118.2%
34,669
+68.5%
0.00%
Q2 2016$33,00020,569
+81.0%
0.00%
Q1 2016$0
-100.0%
11,365
-77.0%
0.00%
Q4 2015$50,000
-95.9%
49,492
-71.4%
0.00%
-100.0%
Q3 2015$1,212,000
+202.2%
173,213
+202.4%
0.00%
Q2 2015$401,000
-57.8%
57,279
-51.8%
0.00%
Q1 2015$950,000
-65.1%
118,900
-60.7%
0.00%
-100.0%
Q4 2014$2,724,000
-38.8%
302,685
-38.8%
0.00%
-50.0%
Q3 2014$4,450,000
+1.2%
494,455
+91.2%
0.00%
-20.0%
Q2 2014$4,397,000
+30.7%
258,647
+30.7%
0.01%
+66.7%
Q1 2014$3,365,000
-37.5%
197,932
-33.8%
0.00%
-50.0%
Q4 2013$5,383,000
-81.9%
299,001
-73.8%
0.01%
-82.9%
Q3 2013$29,663,000
+27.0%
1,140,945
-9.9%
0.04%
+16.7%
Q2 2013$23,354,0001,265,7980.03%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,001,000$970,0000.21%
Allegis Investment Advisors, LLC 341,669$331,0000.19%
GENERAL AMERICAN INVESTORS CO INC 396,123$384,0000.04%
Alambic Investment Management, L.P. 114,591$111,0000.04%
Gruss Capital Management LP 600,000$582,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 102,086$99,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 323,429$314,0000.01%
GSA CAPITAL PARTNERS LLP 27,931$27,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$3,0000.00%
Airain ltd 13,690$13,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders